Register Login
Register to leave comments
  • News bot Oct. 29, 2025, 11:50 a.m.

    🏢 Rain Therapeutics Inc (was acquired by Pathos AI, Inc. (“Pathos”) on 13/12/2023) (RAIN) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-04
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $-14.98M $-35.01M $20.02M +57.20% 📉
    Total Assets $147.14M $110.66M $36.48M +32.96% 📈
    Total Liabilities $16.64M $12.38M $4.26M +34.40% 📉
    Stockholders' Equity $164.83M $-53.55M $218.39M +407.80% 📈
    Operating Income/Loss $-15.00M $-35.17M $20.17M +57.36% 📉
    R&D Expense $10.82M $27.81M $-17.00M -61.11% 📈
    Earningspersharebasic $-1.23 $-1.32 $0.09 +6.82% 📈
    Earningspersharediluted $-1.23 $-1.32 $0.09 +6.82% 📈
    📈

    Financial Trend Analysis

    🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth

    📎 View Full 10-Q Filing on SEC.gov

    Access the complete official filing document

Search

News categories